27 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
10201825	2	Solid-phase synthesis of benzisothiazolones as serine protease inhibitors.	Bristol-Myers Squibb Pharmaceutical Research Institute
26122211	3	Discovery of non-competitive thrombin inhibitor derived from competitive tryptase inhibitor skeleton: Shift in molecular recognition resulted from skeletal conversion of carboxylate into phosphonate.	Tokyo University Of Pharmacy And Life Sciences
16644215	52	Design and synthesis of selective keto-1,2,4-oxadiazole-based tryptase inhibitors.	Celera Genomics
16554154	9	Development of activity-based probes for trypsin-family serine proteases.	Celera Genomics
19715320	87	Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.	University Of Florida
12930148	41	Potent, small-molecule inhibitors of human mast cell tryptase. Antiasthmatic action of a dipeptide-based transition-state analogue containing a benzothiazole ketone.	Johnson & Johnson Pharmaceutical Research & Development
15081015	91	Solid-phase synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors.	The Bristol-Myers Squibb Pharmaceutical Research Institute
16725321	13	Novel, potent, selective, and orally bioavailable human betaII-tryptase inhibitors.	Celera Genomics
16714109	40	Design of novel, potent, and selective human beta-tryptase inhibitors based on alpha-keto-[1,2,4]-oxadiazoles.	Celera
16540315	23	Synthesis and evaluation of 4-substituted benzylamine derivatives as beta-tryptase inhibitors.	Mochida Pharmaceutical
15911249	29	Design, synthesis, and biological activity of potent and selective inhibitors of mast cell tryptase.	Aventis Pharmaceuticals
15745817	14	Combinatorial approaches towards the discovery of new tryptase inhibitors.	University Of Barcelona
15546728	15	Design of bivalent ligands using hydrogen bond linkers: synthesis and evaluation of inhibitors for human beta-tryptase.	Aventis Pharmaceuticals
15341931	15	Novel pyrazinone inhibitors of mast cell tryptase: synthesis and SAR evaluation.	Aventis Pharmaceuticals
15081014	35	Synthesis of potent and highly selective nonguanidine azetidinone inhibitors of human tryptase.	The Bristol-Myers Squibb Pharmaceutical Research Institute
14698147	60	Synthesis of potent and selective 2-azepanone inhibitors of human tryptase.	The Bristol-Myers Squibb Pharmaceutical Research Institute
11959009	7	Bivalent inhibition of beta-tryptase: distance scan of neighboring subunits by dibasic inhibitors.	Institut FüR Biochemie
11527724	30	Monocharged inhibitors of mast cell tryptase derived from potent and selective dibasic inhibitors.	Axys Pharmaceuticals
11425524	62	Dibasic inhibitors of human mast cell tryptase. Part 3: identification of a series of potent and selective inhibitors containing the benzamidine functionality.	Axys Pharmaceuticals
11055356	236	Dibasic inhibitors of human mast cell tryptase. Part 2: structure-activity relationships and requirements for potent activity.	Axys Pharmaceuticals
11055355	72	Dibasic inhibitors of human mast cell tryptase. Part 1: synthesis and optimization of a novel class of inhibitors.	Axys Pharmaceuticals
10612586	34	Syntheses and evaluation of amidinobenzofuran derivatives as tryptase inhibitors.	Yoshitomi Pharmaceutical Industries
9873535	13	Highly efficient and versatile synthesis of libraries of constrained beta-strand mimetics.	Molecumetics